ALLMedicine™ Interstitial Lung Disease Center

May 17th, 2022 - To perform a semiquantitative and quantitative analysis of interstitial lung disease (ILD), through computed tomography (CT), in different serological subgroups of idiopathic inflammatory myopathies (IIM) patients, to find radiologic and clinical ...

May 14th, 2022 - Interstitial lung disease (ILD) is a severe pulmonary complication in inflammatory rheumatic diseases (IRD) and associated with significantly increased morbidity and mortality. That is why ILD screening at a very early stage, at the onset of IRD, ...

May 13th, 2022 - Several safe and effective vaccines against nCoV-19 have been developed to contain the pandemic with very few severe adverse-reactions reported. Vaccine-induced interstitial lung disease (ILD) is a very rare and difficult to recognise and diagnose...

May 10th, 2022 - This study aimed to determine interstitial lung disease (ILD) incidences in patients receiving cancer drug therapies with or without bevacizumab treatment. Systematic searches of PubMed, Embase, and Cochrane Library were conducted in January 2021....

May 4th, 2022 - Home oxygen therapy is prescribed for patients with advanced lung disease based on the criteria established in landmark trials in subjects with COPD. In clinical practice, its use has been extrapolated to other diseases, including interstitial lun...

Nov 30th, 2019 - Transbronchial cryobiopsy (TBC) is increasingly recognized as a potential alternative to surgical lung biopsy (SLB) for the diagnosis of interstitial lung disease (ILD). The goal of this analysis was to examine the literature on TBC as it relates ...

Apr 19th, 2022 - Poor cough-specific quality of life (QOL) was independently associated with respiratory hospitalization, death, and lung transplantation in a large population of well-characterized patients with interstitial lung disease (ILD), new research shows....

Apr 4th, 2022 - Most healthcare providers are comfortable recommending palliative care (PC) for their patients with interstitial lung disease (ILD), but most do so at the time of disease progression, rather than diagnosis, as indicated on survey data from 128 cli...

Mar 22nd, 2022 - Kimberly Showalter, MD, MS Interstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) as well as a leading cause of death in this population. Nintedanib (Ofev) and tocilizumab (Actemra) are both recently approved treatm...

Jan 26th, 2022 - Immune checkpoint inhibitors (ICIs) are at least as effective in patients with advanced non-small cell lung cancer (NSCLC) and mild preexisting interstitial lung disease (ILD) as those without ILD. However, the risk of checkpoint inhibitor pneumon...

Jan 19th, 2022 - Dr Kimberly Showalter Interstitial lung disease (ILD) is a leading cause of morbidity and mortality among individuals with systemic sclerosis (SSc)1 and also negatively affects survival for those with other connective tissue diseases (CTD), includ...